302 related articles for article (PubMed ID: 28627265)
1. ATM, radiation, and the risk of second primary breast cancer.
Bernstein JL; ; Concannon P
Int J Radiat Biol; 2017 Oct; 93(10):1121-1127. PubMed ID: 28627265
[TBL] [Abstract][Full Text] [Related]
2. ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.
McDuff SGR; Bellon JR; Shannon KM; Gadd MA; Dunn S; Rosenstein BS; Ho AY
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1373-1382. PubMed ID: 33545302
[TBL] [Abstract][Full Text] [Related]
3. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
[TBL] [Abstract][Full Text] [Related]
4. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Concannon P; Haile RW; Børresen-Dale AL; Rosenstein BS; Gatti RA; Teraoka SN; Diep TA; Jansen L; Atencio DP; Langholz B; Capanu M; Liang X; Begg CB; Thomas DC; Bernstein L; Olsen JH; Malone KE; Lynch CF; Anton-Culver H; Bernstein JL;
Cancer Res; 2008 Aug; 68(16):6486-91. PubMed ID: 18701470
[TBL] [Abstract][Full Text] [Related]
5. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
[TBL] [Abstract][Full Text] [Related]
6. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
[TBL] [Abstract][Full Text] [Related]
7. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Bernstein JL; Langholz B; Haile RW; Bernstein L; Thomas DC; Stovall M; Malone KE; Lynch CF; Olsen JH; Anton-Culver H; Shore RE; Boice JD; Berkowitz GS; Gatti RA; Teitelbaum SL; Smith SA; Rosenstein BS; Børresen-Dale AL; Concannon P; Thompson WD;
Breast Cancer Res; 2004; 6(3):R199-214. PubMed ID: 15084244
[TBL] [Abstract][Full Text] [Related]
8. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
[TBL] [Abstract][Full Text] [Related]
9. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.
Broeks A; Braaf LM; Huseinovic A; Nooijen A; Urbanus J; Hogervorst FB; Schmidt MK; Klijn JG; Russell NS; Van Leeuwen FE; Van 't Veer LJ
Breast Cancer Res; 2007; 9(2):R26. PubMed ID: 17428320
[TBL] [Abstract][Full Text] [Related]
10. Ataxia-telangiectasia gene (
Jerzak KJ; Mancuso T; Eisen A
Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
[TBL] [Abstract][Full Text] [Related]
11. ATM mutations for surgeons.
Mansfield SA; Pilarski R; Agnese DM
Fam Cancer; 2017 Jul; 16(3):407-410. PubMed ID: 27988859
[TBL] [Abstract][Full Text] [Related]
12. Association between ATM gene polymorphisms, lung cancer susceptibility and radiation-induced pneumonitis: a meta-analysis.
Yan Z; Tong X; Ma Y; Liu S; Yang L; Yang X; Yang X; Bai M; Fan H
BMC Pulm Med; 2017 Dec; 17(1):205. PubMed ID: 29246212
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
Nichols KE; Levitz S; Shannon KE; Wahrer DC; Bell DW; Chang G; Hegde S; Neuberg D; Shafman T; Tarbell NJ; Mauch P; Ishioka C; Haber DA; Diller L
J Clin Oncol; 1999 Apr; 17(4):1259. PubMed ID: 10561187
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.
Shafman TD; Levitz S; Nixon AJ; Gibans LA; Nichols KE; Bell DW; Ishioka C; Isselbacher KJ; Gelman R; Garber J; Harris JR; Haber DA
Genes Chromosomes Cancer; 2000 Feb; 27(2):124-9. PubMed ID: 10612799
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
[TBL] [Abstract][Full Text] [Related]
16. Association of common ATM polymorphism with bilateral breast cancer.
Heikkinen K; Rapakko K; Karppinen SM; Erkko H; Nieminen P; Winqvist R
Int J Cancer; 2005 Aug; 116(1):69-72. PubMed ID: 15756685
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
[TBL] [Abstract][Full Text] [Related]
18. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
19. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
20. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
